6ms7: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
'''Unreleased structure'''


The entry 6ms7 is ON HOLD  until Paper Publication
==Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective PPAR-gamma modulator VSP-77==
 
<StructureSection load='6ms7' size='340' side='right'caption='[[6ms7]], [[Resolution|resolution]] 1.43&Aring;' scene=''>
Authors: Yi, W., Jiang, H., Zhou, X.E., Shi, J., Zhao, G., Zhang, X., Sun, Y., Suino-Powell, K., Li, J., Li, J., Melcher, K., Xu, H.E.
== Structural highlights ==
 
<table><tr><td colspan='2'>[[6ms7]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MS7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6MS7 FirstGlance]. <br>
Description: Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective PPAR-gamma modulator VSP-77
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=V77:{[(1S)-1-(4-chlorophenyl)octyl]oxy}acetic+acid'>V77</scene></td></tr>
[[Category: Unreleased Structures]]
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ms7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ms7 OCA], [http://pdbe.org/6ms7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ms7 RCSB], [http://www.ebi.ac.uk/pdbsum/6ms7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ms7 ProSAT]</span></td></tr>
[[Category: Zhou, X.E]]
</table>
[[Category: Xu, H.E]]
== Disease ==
[[http://www.uniprot.org/uniprot/PPARG_HUMAN PPARG_HUMAN]] Note=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer.  Defects in PPARG may be associated with susceptibility to obesity (OBESITY) [MIM:[http://omim.org/entry/601665 601665]]. It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.<ref>PMID:9753710</ref>  Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) [MIM:[http://omim.org/entry/604367 604367]]. Familial partial lipodystrophies (FPLD) are a heterogeneous group of genetic disorders characterized by marked loss of subcutaneous (sc) fat from the extremities. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus and dyslipidemia.<ref>PMID:12453919</ref> <ref>PMID:11788685</ref>  Genetic variations in PPARG can be associated with susceptibility to glioma type 1 (GLM1) [MIM:[http://omim.org/entry/137800 137800]]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Polymorphic PPARG alleles have been found to be significantly over-represented among a cohort of American patients with sporadic glioblastoma multiforme suggesting a possible contribution to disease susceptibility.  
== Function ==
[[http://www.uniprot.org/uniprot/PPARG_HUMAN PPARG_HUMAN]] Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses.<ref>PMID:9065481</ref> <ref>PMID:16150867</ref> <ref>PMID:20829347</ref> 
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Large Structures]]
[[Category: Jiang, H]]
[[Category: Li, J]]
[[Category: Melcher, K]]
[[Category: Melcher, K]]
[[Category: Li, J]]
[[Category: Shi, J]]
[[Category: Suino-Powell, K]]
[[Category: Sun, Y]]
[[Category: Xu, H E]]
[[Category: Yi, W]]
[[Category: Yi, W]]
[[Category: Zhang, X]]
[[Category: Zhang, X]]
[[Category: Jiang, H]]
[[Category: Shi, J]]
[[Category: Zhao, G]]
[[Category: Zhao, G]]
[[Category: Suino-Powell, K]]
[[Category: Zhou, X E]]
[[Category: Sun, Y]]
[[Category: Dna binding protein]]
[[Category: Lignad binding domain]]
[[Category: Peroxisome proliferator-activated receptor gamma]]
[[Category: Selective ppar gamma modulator]]
[[Category: Transcription]]
[[Category: Vsp-77]]

Revision as of 06:52, 23 October 2019

Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective PPAR-gamma modulator VSP-77

6ms7, resolution 1.43Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA